Austin, TX, April 26, 2012 --(PR.com
)-- Bioo Scientific announced today that it has launched the proprietary MyeloAim™ and NeuroAim™ Transduction Reagents which offer directed delivery of RNAi agents into myeloid cells (both in primary cells and in cell lines) or into neuronal cells (both in primary cells and in cell lines) respectfully.
These transduction reagents are able to transduce siRNA to targeted cells both in vitro and in vivo resulting in efficient gene silencing in cells of human, mouse, and rat origin. The MyeloAim™ and NeuroAim™ Transduction Reagents provide a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules to these cells.
According to Dr. Sandesh Subramanya, Senior Scientist at Bioo Scientific, “The NeuroAim and MyeloAim transduction reagents are the only delivery vehicles available in the market for cell-specific delivery of siRNA and miRNA. These are valuable tools for researchers that focus on studies that require delivering therapeutic small RNAs to neuronal cells and myeloid cells. A huge advantage here is that all payload can ‘selectively hit the mark’ by minimizing targeting to non-specific tissues and cells, be well tolerated, and provide a high therapeutic index.”
About Bioo Scientific Corporation
Founded in 2003, Bioo Scientific Corporation is an Austin, TX based biotechnology company that provides innovative solutions to the life science and food safety industries. Bioo Scientific’s products are used around the world and can be purchased both directly or through our global distribution network that markets our products in more than 100 countries. For more information about Bioo Scientific, visit www.biooscientific.com.